SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Timothy R. Bowers who wrote (45)4/18/1997 5:19:00 AM
From: Thomas G. Magnani   of 369
 
When Special Situations Report (put out by Individual Investor) first recommended this one, they made a statement that kept me from buying it. That is, they said that the use of the product caused a high incidence of urinary tract infections. They downplayed this as treatable by antibiotics, however, anyone who has had one of these would not take it so lightly. In fact, if someone was to get recurring infections from this, the continued use of antibiotics would risk the chance of becoming immune to the effects of the antibiotic. Anyway, I'm not a doctor, but I wonder if this has kept the sales and acceptance of this product from becoming the great success that was envisioned for it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext